Spyre Therapeutics, Inc. (SYRE) rose 11.31% to $21.06, up $2.14, following the announcement of a $275 million public offering of common stock at $18.50 per share.
The stock opened at $19.15, hit a high of $21.41 and a low of $18.30, versus a previous close of $18.92. It trades on the NASDAQ, with a volume of 2.87 million shares, sharply above its average.
The 52-week range is $12.10 to $21.41.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.